CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.10
-0.10 (-0.19%)
Apr 28, 2026, 2:00 PM CST
24.21%
Market Cap 11.39B
Revenue (ttm) 1.43M
Net Income (ttm) -290.01M
Shares Out 214.01M
EPS (ttm) -1.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 515,287
Average Volume 1,163,309
Open 53.20
Previous Close 53.20
Day's Range 52.80 - 55.60
52-Week Range 22.75 - 68.30
Beta -0.40
RSI 64.38
Earnings Date May 13, 2026

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 47
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.